Today, the U.S. Food and Drug Administration approved Narcan, 4 milligram (mg) naloxone hydrochloride nasal spray for over-the-counter (OTC), nonprescription, use – the first naloxone product approved for use without a prescription.
FDA Approves First Over-the-Counter Naloxone Nasal Spray Read More »
Join us for Part 1 of our rural telehealth webinar series, Leveraging Telehealth to Improve Access and Reach in Rural Integrated Care, on Thursday, April 20, 2-3:30 p.m. ET…
Webinar Series: Telehealth in Rural Integrated Care Read More »
The next webinar in the “Moving from Hepatitis Discovery to Elimination: NIH Research Advancing Hepatitis Elimination” series will be hosted by the National Institute on Drug Abuse. Speakers will discuss collaborative research on hepatitis C networks among persons who inject drugs, using peers and technology to increase uptake of HCV screening & treatment, and Hepatitis C elimination
Hepatitis C Elimination at the Intersection of People Who Inject Drugs in Rural Settings Read More »
SAMHSA is alerting providers and grantees to the risks associated with Xylazine. Xylazine is a non-opioid agent increasingly found in combination with opioids such as fentanyl. This alert offers information regarding the risks posed by Xylazine and to how to prepare to manage patients. The alert by Assistant Secretary for Mental Health and Substance Use, Dr. Miriam E. Delphin-Rittmon, warns that since Xylazine is not an opioid, naloxone does not reverse the effects and severe withdrawal symptoms may occur which are not managed by medications for Opioid Use Disorders. Xylazine may present new potential public health challenges regarding overdose, withdrawal, and severe necrotic skin ulcerations.
Click here to view the letter from Dr. Miriam E. Delphin-Rittmon
SAMHSA Alert on Xylazine Read More »
SAMHSA has issued a report on “Moving Beyond Change Efforts: Evidence and Action to Support and Affirm LGBTQI+ Youth.” This report provides behavioral health professionals, researchers, policymakers and other audiences with a comprehensive research overview and accurate information about effective and ineffective therapeutic practices related to youth of diverse sexual orientation and gender identity.
Moving Beyond Change Efforts: Evidence and Action to Support and Affirm LGBTQI+ Youth Read More »